Clinical Consideration of Using Oral Antiviral Therapy for Symptomatic Mild to Moderate COVID-19 Cases

Date of Event:
2022-04-02
Time:
14:00 - 15:20
Organiser:

The Society of Hospital Pharmacists of Hong Kong

Supporting Organisation:

Pfizer Corporation Hong Kong Limited

Moderator:

Mr. Ng Man Keung, General Committee Member of SHPHK

Speaker:

14:00 – 14:30
Considerations for the use of Molnupiravir to treat COVID-19
By Mr. Raymond Mak
Pharmacist of The Society of Hospital Pharmacists of Hong Kong

14:30 – 15:00
Considerations for the use of Nirmatrelvir/Ritonavir to treat COVID-19 
By William C M Chui
Honorary Director, Centre for Medication Safety Practice and Research, The University of Hong Kong

15:00 - 15:20

Q&A



Related Events: